Disc Medicine (IRON) Net Equity Issued and Repurchased (2020 - 2023)

Disc Medicine's (IRON) quarterly Net Equity Issued and Repurchased came in at -$20.0 million in Q4 2023, down 158.45% on a QoQ basis from $34.2 million in Q1 2023.

Disc Medicine (IRON) Net Equity Issued and Repurchased (2020 - 2023) Analysis & Trends

Disc Medicine (IRON) has 2 years of Net Equity Issued and Repurchased data on file, last reported at -$20.0 million in Q4 2023.

  • On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to -$20.0 million in Q4 2023; TTM through Dec 2023 was $14.2 million, a N/A change from a year earlier, with the FY2022 full-year figure at $53.5 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased for Q4 2023 stood at -$20.0 million, down from $34.2 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for IRON reached as high as $34.2 million in Q1 2023 and fell as low as -$20.0 million in Q4 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 163.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 141.90 Mn
10 Disc Medicine 2.90 Bn 2.90 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 -20.00 Mn
Dec 31, 2023 -20.00 Mn
Mar 31, 2023 34.22 Mn
Mar 31, 2023 34.22 Mn
Dec 31, 2020 25,000.00
Dec 31, 2020 25,000.00
Sep 30, 2020 25,000.00
Sep 30, 2020 25,000.00
Mar 31, 2020 20.08 Mn
Mar 31, 2020 20.08 Mn